Literature DB >> 23431028

The long-term effect of ambulatory oxygen in normoxaemic COPD patients: a randomised study.

Thomas Ringbaek1, Gerd Martinez, Peter Lange.   

Abstract

AIM: To study the long-term benefits of ambulatory oxygen (AO) in combination with pulmonary rehabilitation (PR) in chronic obstructive pulmonary disease (COPD) patients experiencing exertional desaturation. PATIENTS AND METHODS: Normoxaemic COPD who participated in outpatient PR and desaturated >4% and <90% during endurance shuttle walk test (ESWT) were randomised to control (n=23) or AO 2 L/min from a portable oxygen concentrator (n=22) to be used during exercise. PR consisted of supervised training for 20 weeks combined with unsupervised daily training at home followed by 13 weeks without supervised training.
RESULTS: Only 45 of 165 eligible patients wanted to participate. Mean forced expiratory volume in 1 s=32% (SD 13.8) and Medical Research Council (MRC)=4.5 (3-5). Supplemental oxygen improved oxygen saturation during ESWT by 2.3% (95% CI: 1.2%-3.5%; p<0.001). In the study period of 33 weeks, 10 and 6 patients withdrew from the AO group and control group, respectively. Patients spent an average of 7.9 h/week on oxygen. PR improved ESWT by 18,076 s (95% CI: 101-258 s; p<0.001) and St. George's Respiratory Questionnaire (SGRQ) score by 2.6 units (95% CI: 0.1-5.1 s; p=0.04) after 7 weeks, and these gains remained at 33 weeks of evaluation. There were no differences between the AO group and control group at 33 weeks of evaluation with regard to change in ESWT (223 vs. 241 s; p=0.32), change in SGRQ (-3.6 vs. -4.5 units, 0.91), and number of patients with acute exacerbation in COPD (AECOPD), hospital admission or dropout (17 of 22 vs. 20 of 23, p=0.59).
CONCLUSIONS: AO seems not to provide additional beneficial effects in patients with COPD participating in pulmonary rehabilitation and experiencing exertional desaturation without severe resting hypoxaemia.

Entities:  

Mesh:

Year:  2013        PMID: 23431028     DOI: 10.1177/1479972312473135

Source DB:  PubMed          Journal:  Chron Respir Dis        ISSN: 1479-9723            Impact factor:   2.444


  14 in total

1.  Long-term oxygen for COPD with moderate desaturation.

Authors:  Ludovico Furlan; Luca Erba
Journal:  Intern Emerg Med       Date:  2017-02-10       Impact factor: 3.397

2.  Ambulatory Oxygen for Exercise-Induced Desaturation and Dyspnea in Chronic Obstructive Pulmonary Disease (COPD): Systematic Review and Meta-Analysis.

Authors:  Stanley I Ejiofor; Susan Bayliss; Abubacarr Gassamma; Alice M Turner
Journal:  Chronic Obstr Pulm Dis       Date:  2016-01-06

Review 3.  Celebration of the 50-Year Anniversary of the National Heart, Lung, and Blood Institute Division of Lung Diseases: A Half-Century of Landmark Clinical Trials.

Authors:  Robert A Wise; Jerry A Krishnan
Journal:  Chronic Obstr Pulm Dis       Date:  2019-10-23

4.  A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.

Authors:  Richard K Albert; David H Au; Amanda L Blackford; Richard Casaburi; J Allen Cooper; Gerard J Criner; Philip Diaz; Anne L Fuhlbrigge; Steven E Gay; Richard E Kanner; Neil MacIntyre; Fernando J Martinez; Ralph J Panos; Steven Piantadosi; Frank Sciurba; David Shade; Thomas Stibolt; James K Stoller; Robert Wise; Roger D Yusen; James Tonascia; Alice L Sternberg; William Bailey
Journal:  N Engl J Med       Date:  2016-10-27       Impact factor: 91.245

5.  Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: a cohort study.

Authors:  J Michael Wells; Raul San Jose Estepar; Merry-Lynn N McDonald; Surya P Bhatt; Alejandro A Diaz; William C Bailey; Francine L Jacobson; Mark T Dransfield; George R Washko; Barry J Make; Richard Casaburi; Edwin J R van Beek; Eric A Hoffman; Frank C Sciurba; James D Crapo; Edwin K Silverman; Craig P Hersh
Journal:  BMC Pulm Med       Date:  2016-12-01       Impact factor: 3.317

6.  A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol.

Authors:  David Currow; Gareth John Watts; Miriam Johnson; Christine F McDonald; John O Miners; Andrew A Somogyi; Linda Denehy; Nicola McCaffrey; Danny J Eckert; Philip McCloud; Sandra Louw; Lawrence Lam; Aine Greene; Belinda Fazekas; Katherine C Clark; Kwun Fong; Meera R Agar; Rohit Joshi; Sharon Kilbreath; Diana Ferreira; Magnus Ekström
Journal:  BMJ Open       Date:  2017-07-17       Impact factor: 2.692

Review 7.  Effect of "add-on" interventions on exercise training in individuals with COPD: a systematic review.

Authors:  Carlos A Camillo; Christian R Osadnik; Hans van Remoortel; Chris Burtin; Wim Janssens; Thierry Troosters
Journal:  ERJ Open Res       Date:  2016-03-29

8.  Daily duration of long-term oxygen therapy and risk of hospitalization in oxygen-dependent COPD patients.

Authors:  Josefin Sundh; Zainab Ahmadi; Magnus Ekström
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-08-28

9.  When should I be considering home oxygen for my patients?

Authors:  Jay Suntharalingam; Sabrine Hippolyte; Vikki Knowles; Daryl Freeman; Irem Patel; Maxine Hardinge
Journal:  NPJ Prim Care Respir Med       Date:  2016-01-07       Impact factor: 2.871

10.  Tablet computers to support outpatient pulmonary rehabilitation in patients with COPD.

Authors:  Thomas J Ringbaek; Marie Lavesen; Peter Lange
Journal:  Eur Clin Respir J       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.